Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 16, 1986 - Issue 1
35
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Further studies on the pharmacokinetics of perhexiline maleate in humans

, , &
Pages 63-68 | Received 02 Mar 1984, Accepted 12 Aug 1985, Published online: 30 Sep 2009
 

Abstract

1. We have performed single-dose pharmacokinetic studies on perhexiline in eight young volunteers, each given 300 mg of Pexid orally, using an h.p.l.c. method for the separation and quantification of the drug and its monohydroxy metabolites in plasma and urine.

2. The plasma concentration of the cis-monohydroxyperhexiline (peak of 473 ± 43 ng/ml at 7.5 ± 2.0 h) was always higher than for unchanged perhexiline (peak of 112 ± 20 ng/ml at 6.5 ± 2.0 h) whereas the concentration of the transmetabolite was either low or undetectable in plasma. These findings indicate the occurrence of stereospecific pre-systemic metabolism of perhexiline which reduces the bioavailability of the parent drug. The plasma elimination half-life of perhexiline was 12.4 ± 6.1 h (range 7–23 h) while that for cis-monohydroxyperhexiline was 19.9 ± 7.7 h (range 10–29 h).

3. Not more than 0.3% of unchanged perhexiline was excreted in the urine over five days in eight subjects. Between 3 and 23% of the orally administered drug was excreted as the cis-or trans-monohydroxy metabolites, the ratio of trans to cis metabolites being 0.52 ± 0.20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.